Dr Ken Gillman, MD
Critical independent evaluations in psycho-pharmacology
Menu
Duloxetine does not have a ‘badge-engineered’ metabolite derivative to extend its patent, unlike Venlafaxine (Effexor, now out of patent), and its patent-extending-metabolite, desvenlafaxine.This commentary will be short because it is…
Venlafaxine (Effexor, now out of patent) and its ‘badge-engineered’ metabolite off-spring (desvenlafaxine, Pristiq- in patent, which is even weaker than venlafaxine as an NRI) are examples of drugs whose attribution…
Introduction: 50th birthday tributeClomipramine (CMI) is usually thought of by doctors as a treatment for obsessive-compulsive disorder (OCD). However, it is a potent antidepressant with dual SNRI action (see tables of comparative…
PsychoTropical is a knowledge and education resource started by Dr Gillman about 20 years ago. It is neither connected with, nor influenced by, any financial backing or interest group of any sort. The opinions expressed relate to Dr Gillman’s special knowledge and expertise as a recognised world-expert in MAOIs and serotonin toxicity.
© PsychoTropical 2022. All Rights Reserved